background image

Alopecia Clinical Trials

Find clinical trials for Alopecia. Search for Alopecia clinical trials in different cities and states across the United States.

Filter
1

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors

Recruiting

Sponsor:

St. Jude Children's Research Hospital

Location:

Memphis

Code:

NCT04764357

Conditions

Alopecia

Eligibility Criteria

Sex: All

Age: 7+

Healthy Volunteers: Not accepted

Interventions

Paxman Scalp Cooling System

Alopecia Assessments

Patient Reported Outcomes Questionnaires

Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia Areata

Recruiting
EARLY_PHASE1

Sponsor:

The University of Texas Health Science Center, Houston

Location:

Houston

Code:

NCT05414266

Conditions

Alopecia Areata

Eligibility Criteria

Sex: All

Age: 12 - 18

Healthy Volunteers: Not accepted

Interventions

Placebo

SADBE 5%

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting

Sponsor:

Target PharmaSolutions, Inc.

Location:

Scottsdale, Fort Smith, Little Rock, Fountain Valleyshow 51 more

Code:

NCT03661866

Conditions

Atopic Dermatitis

Alopecia Areata

Hidradenitis Suppurativa

Vitiligo

Psoriasis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)

Recruiting
PHASE2

Sponsor:

Nektar Therapeutics

Location:

Northridge, Atlanta, Gurnee, Indianapolisshow 11 more

Code:

NCT06340360

Conditions

Alopecia Areata

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Rezpegaldesleukin

Placebo

Dupilumab in the Treatment of Pediatric Alopecia Areata

Recruiting
PHASE2

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

Irvine, Chicago, New York

Code:

NCT05866562

Conditions

Alopecia Areata

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Dupilumab

Placebo

Safety and Efficacy of VDPHL01 in Males and Females with AGA

Recruiting
PHASE2

Sponsor:

Veradermics, Inc.

Location:

San Diego, New Albany, Hackensack, South Jordan

Code:

NCT06527365

Conditions

Androgenetic Alopecia

AGA

Male Pattern Baldness

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

VDPHL01

A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Recruiting

Sponsor:

Wake Forest University Health Sciences

Location:

Winston-Salem

Code:

NCT04764331

Conditions

Central Centrifugal Cicatricial Alopecia

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Revian Red All LED cap

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

Recruiting
PHASE3

Sponsor:

Cassiopea SpA

Location:

North Little Rock, San Diego, Jacksonville, Miamishow 12 more

Code:

NCT05910450

Conditions

Alopecia, Androgenetic

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Clascoterone 5% solution

Vehicle solution

Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)

Recruiting

Sponsor:

UCLA

Location:

San Francisco

Code:

NCT06215469

Conditions

Breast Cancer

Early-stage Breast Cancer

Hair Loss

Alopecia

Chemotherapy-induced Alopecia

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Amma Portable Scalp Cooling System (PSCS)

Questionnaires

Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia

Recruiting

Sponsor:

Bellevue Dermatology

Location:

Bellevue

Code:

NCT03422640

Conditions

Frontal Fibrosing Alopecia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Apremilast